Kurome Therapeutics has a total of 16 patents globally. Of these 16 patents, more than 81% patents are active. Europe (EPO) is where Kurome Therapeutics has filed the maximum number of patents, followed by Israel, Brazil, Australia and Canada. Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of Kurome Therapeutics.
Kurome Therapeutics was founded in the year 2019. Kurome Therapeutics is a preclinical stage startup whose goal is to undermine cancer’s resistance to treatment.
Do read about some of the most popular patents of Kurome Therapeutics which have been covered by us in this article and also you can find Kurome Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kurome Therapeutics patent portfolio.
How many patents does Kurome Therapeutics have?
Kurome Therapeutics has a total of 16 patents globally. These patents belong to 5 unique patent families. Out of 16 patents, 13 patents are active.
How Many Patents did Kurome Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Kurome Therapeutics Applications Filed | Kurome Therapeutics Patents Granted |
| 2023 | 3 | – |
| 2022 | 1 | – |
| 2021 | 12 | – |
How many Kurome Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Kurome Therapeutics File in Different Countries?
Countries in which Kurome Therapeutics Filed Patents
| Country | Patent |
| Europe | 3 |
| Israel | 2 |
| Brazil | 2 |
| Australia | 2 |
| Canada | 2 |
Where are Research Centers of Kurome Therapeutics Patents Located?
The Research Centre of Kurome Therapeutics patents is the United States of America.
List of Kurome Therapeutics patents
| Kurome Therapeutics Patents | Title |
| EP4267142A1 | Multi-Cyclic Irak And Flt3 Inhibiting Compounds And Uses Thereof |
| EP4262802A1 | Multi-Cyclic Irak And Flt3 Inhibiting Compounds And Uses Thereof |
| EP4188926A1 | Multi-Cyclic Irak And Flt3 Inhibiting Compounds And Uses Thereof |
| WO2023150601A3 | Multi-Cyclic Irak And Flt3 Inhibiting Compounds And Uses Thereof |
| WO2023009833A1 | Multi-Cyclic Irak And Flt3 Inhibiting Compounds And Uses Thereof |
| AU2021410783A1 | Multi-Cyclic Irak And Flt3 Inhibiting Compounds And Uses Thereof |
| AU2021403015A1 | Multi-Cyclic Irak And Flt3 Inhibiting Compounds And Uses Thereof |
| CA3201841A1 | Multi-Cyclic Irak And Flt3 Inhibiting Compounds And Uses Thereof |
| CA3201690A1 | Multi-Cyclic Irak And Flt3 Inhibiting Compounds And Uses Thereof |
| IL303887A | Multi-Cyclic Irak And Flt3 Inhibiting Compounds And Uses Thereof |
| IL303709A | Multi-Cyclic Irak And Flt3 Inhibiting Compounds And Uses Thereof |
| BR112023012586A2 | Compound Of Formula (I), Composition And Method Of Treatment Of A Disease Or Disorder |
| BR112023011636A2 | Compound, Composition And Method For Treatment Of A Disease Or Disorder |
| WO2022140647A1 | Multi-Cyclic Irak And Flt3 Inhibiting Compounds And Uses Thereof |
| WO2022132936A1 | Multi-Cyclic Irak And Flt3 Inhibiting Compounds And Uses Thereof |
| WO2022026935A1 | Multi-Cyclic Irak And Flt3 Inhibiting Compounds And Uses Thereof |
What are Kurome Therapeutics key innovation segments?
What Technologies are Covered by Kurome Therapeutics?
The chart below distributes patents filed by Kurome Therapeutics